Actos and Bladder Cancer

Our Law Firm is currently assisting individuals who have been diagnosed with Bladder Cancer that may have been caused by taking the diabetic drug Actos.

Call our Offices for more information.

It is now understood that a side effects of taking Actos, that contains the active ingredient drug known as pioglitazone the individual can develop Bladder Cancer.

Call our Offices for we are proceeding with assisting individuals diagnosed with cancer in filing an Actos bladder cancer lawsuit.

It is now understood that the drug pioglitazone (also referred to by the brand name Actos) which is prescribed to treat diabetes has been linked to an increased risk of developing bladder cancer in patients taking the medicine for longer than one year.

In June 2011 the FDA made a formal announcement that that patients using the diabetes medicine Actos (generic name - pioglitazone) for longer than a year may be linked with an elevated risk for developing bladder cancer. Actos is the brand name of the drug pioglitazone and is manufactured by Takeda. It is prescribed to treat adults diagnosed with type 2 diabetes mellitus. For the first ten months in 2010, it is estimated 2.3 million people filled a prescription from a retail pharmacy for medication containing pioglitazone.

The FDA has studied from a five year analysis that was based on an ongoing epidemiological study. This data formed the basis of the FDA’s safety information reported to the public regarding the link between Actos and bladder cancer. The FDA found that the longer patients took drugs containing pioglitazone, like Actos, the greater the risk of developing bladder cancer. The same Actos bladder cancer connection was also found in patients with the highest cumulative dose of the drug.

Actos is available in several medication forms including:

• Actos (pioglitazone)
• Actoplus Met (pioglitazone/metformin)
• Actoplus Met XR (pioglitazone/metformin extended-release)
• Duetact (pioglitazone/glimepiride)

In June, 2011 the FDA approved Actos drug labeling changes that involved updated safety information regarding the higher risk of developing bladder cancer for patients using the drug for longer than one year. In addition, the updated warning label included information warning that patients who have a history of bladder cancer or currently have bladder cancer should not be prescribed Actos.

Call our Offices today - We represent all Actos lawsuit bladder cancer clients on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please call toll free or fill out our short online contact form and an Actos bladder cancer lawyer will contact you to answer any of your questions. Call 800-862-1260.